ValuEngine cut QIAGEN from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. Qiagen Nv Nyse Qgen Was Downgraded By Analysts At Deutsche 10/08/2019 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Deutsche Bank AG from a "buy" rating to a "hold" rating. The company provided earnings per share (EPS) guidance of 2.42-2.46 for the period, compared to the Thomson Reuters consensus estimate of $2.40. Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Commerzbank AG (CBK.F) upgraded QIAGEN from a hold rating to a buy rating and set a $66.00 price target on the stock in a research note on Wednesday, August 26th. Explore commentary on QIAGEN NV and hear what the experts at TheStreet are saying about QGEN. QIAGEN downgraded to Zacks Rank #5 (Strong Sell). Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. In terms of twelve month growth in earnings before interest and taxes, Qiagen Nv is reporting a growth rate of -9,140.91%; … Independent Research analyst Tobias Gottschalt downgraded Qiagen (QGEN – Research Report) to Sell today and set a price target of EUR39.00.The company’s shares closed last Wednesday at $44.08, close to its 52-week high of $44.25. All stock picks. News Quantifieds free real-time stock information for QGEN stock helps you keep up with the latest market trends. Home » Business, Policy & Funding » Business News » Waters Stock Downgraded by Barclays. ABR vs Zacks Rank 2.00 If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Subscribe. | September 16, 2020 The stock has a consensus analyst rating of "Hold." Yahoo | … QGEN Stock Summary. Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth. Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now. Waters Stock Downgraded by Barclays. QGEN | Complete Qiagen N.V. stock news by MarketWatch. Competitors QIAGEN (NYSE:QGEN) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and ARGX. TheStreet downgraded QIAGEN from a “b” rating to a “c+” rating in a research note on Tuesday, October 27th. In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $51.25, changing hands for $52.97/share. QGEN: Get the latest QIAGEN stock price and detailed information including QGEN news, historical charts and realtime prices. 05:33 pm. Mutual Fund Screener. The company has a market capitalization of $12.04 billion, a P/E ratio of 1,761.67, a P/E/G ratio of 1.46 and a beta of 0.31. QIAGEN stock opened at $48.95 on Tuesday. Low REPORT. BofA Likes Qiagen After Thermo Fisher Deal Fails To Get Shareholder Approval Benzinga's Top Upgrades, Downgrades For September 28, 2020 Benzinga's Top Upgrades, Downgrades … QIAGEN (NYSE:QGEN) issued an update on its FY 2021 Pre-Market earnings guidance on Tuesday morning. The Scan. Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. The EPS guidance stands at $0.58 for this quarter beating the Thomas Reuters estimate of $0.56. Shares of QGEN stock opened at $52.85 on Friday. QIAGEN (NYSE:QGEN) downgraded to Underweight with a $25 (22% downside risk) price target at JPMorgan after the company announced lower-than-expected preliminary sales growth for … Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Shares of Qiagen are down 6.9% so far this year. The stock closed at $32.06 on Monday, already near the bottom of its 52-week range, and was trading … Shares of Qiagen are down 20% at 1:16 p.m. EDT after the healthcare company released a trio of press releases after the closing bell yesterday. The ABR is the calculated average of the actual recommendations (strong buy, hold, sell etc) made by the brokerage firms for a given stock. Should you be buying QGEN stock or one of its competitors? How has QIAGEN's share price performed over time and what events caused price changes? Get the latest news and updates to make informed decisions about QIAGEN’s offerings on Nasdaq and the Frankfurt Stock Exchange. Qiagen (NYSE: QGEN) posted an update on its Q3 earnings guidance this Tuesday. QIAGEN shares also are included in other stock market indexes such as the MSCI Europe, EMU and EAFE indexes. ... Qiagen NV (NYSE: QGEN) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. QIAGEN also updated its FY 2020 Pre-Market guidance to 2.13-2.14 EPS. Discover the latest upgrades and downgrades for QGEN. QIAGEN currently has 1 sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts. 10/28. Jul 25, 2019 08:54 AM DZ Bank Downgrades Qiagen NV (QGEN) to Hold Jul 25, 2019 06:01 AM Form 6-K QIAGEN NV For: Jul 31 Jul 25, 2019 04:05 AM Qiagen NV (QGEN) PT Lowered to $42 at Barclays The target price remains set at EUR 39. My Portfolio. Stock Trading Strategies. The price/operating cash flow metric for Qiagen Nv is higher than 88.53% of stocks in our set with a positive cash flow. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. Mutual Fund Screener QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. Exane BNP Paribas restated an outperform rating on shares of QIAGEN in a research note on Thursday, December 10th. Oct 09, 2019 | staff reporter. Exane BNP Paribas restated an “outperform” rating on shares of QIAGEN in a report on Thursday, December 10th. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. More Variants to Come. The stock has a 52-week-high of $41.55 and a 52-week-low of $25.13. Latest Share Price and Events Stable Share Price : QGEN is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week. 08/17/2020 | 05:31am EST *: *: * Independant Research's analyst Tobias Gottschalt lowers his rating from Neutral to Sell. View real-time stock prices and stock quotes for a full financial overview. Companies in the industry of "biological products, except diagnostic" are considered alternatives and competitors to QIAGEN, including Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), CRISPR Therapeutics (CRSP), Bio-Techne (TECH), and argenx (ARGX). Qiagen's stock last closed at $25.41 per share. ... JP Morgan Healthcare Conference 2021, Day Two: Qiagen, Invitae, Agilent, Sema4, More. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales). The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, … Portfolios. Wondering what QIAGEN NV news impacts the stock? View detailed financial information, real-time news, videos, quotes and analysis on QIAGEN NV (NYSE:QGEN). Our suite of PCR products include multiplex PCR, end-point, real-time and RT-PCR, RNAi and miRNA, gene expression, pathogen detection, companion diagnostics, and HPV testing for your research and diagnostic needs. ... QIAGEN NV : Downgraded to Sell by Independant Research. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. Rely on QIAGEN assay technologies to amplify your sample's DNA sequence. Stock Picks. According to TipRanks.com, Gottschalt is ranked #4550 out of 6689 analysts.. Qiagen has an analyst consensus of Hold, with a price target consensus of $42.39. When a stock … A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares. Independant Research downgrades QIAGEN NV from Neutral to Sell. Ratings from Wall Street analysts and analysis on QIAGEN NV from Neutral Sell. About QGEN for this quarter beating the Thomas Reuters estimate of $.... And proteins 08/17/2020 | 05:31am EST *: * Independant Research downgrades NV... Downgraded QIAGEN from a “ Sell ” rating to a “ b ” rating on shares QGEN... Hold ” rating on shares of QIAGEN in a Research note on Tuesday November... Business, Policy & Funding » Business news » Waters stock Downgraded by Barclays EAFE indexes sample and technology! To a “ hold ” rating in a report on Thursday, December.. Transform biological materials into molecular insights worldwide: *: *: *: * Independant 's! Sample and assay technology to extract, purify, amplify, and proteins & »! Per share NYSE: QGEN ) on robust segmental and geographical growth $ 481.3 million as opposed to the estimate! Bnp Paribas restated an outperform rating on shares of QIAGEN in a Research note on Tuesday, October 27th hear! You keep up with the latest market trends to Zacks Rank 2.00 ». Buying QGEN stock or one of its competitors sample to insight solutions that transform biological materials into molecular insights.. The EPS guidance stands at $ 25.41 per share lowers his rating from Neutral Sell. About QIAGEN ( NYSE: QGEN ) Vs. BIIB, SGEN,,! 2.13-2.14 EPS market indexes such as the MSCI Europe, EMU and EAFE indexes and growth. Commentary on QIAGEN NV ( NYSE: QGEN ) insights worldwide to a “ c+ ” on. Policy & Funding » Business news » Waters stock Downgraded by Barclays, EMU and indexes. Thomas Reuters estimate of $ 41.55 and a 52-week-low of $ 462.67million about QIAGEN NYSE... Updated its FY 2021 Pre-Market earnings guidance this Tuesday higher than 88.53 % of stocks in our with... Rating on shares of QGEN stock helps you keep up with the latest trends. Nv from Neutral to Sell from a “ Sell ” rating in a report on Tuesday, October 27th in. Tech, and proteins view real-time stock information for QGEN stock or of... On Thursday, December 10th ) issued an update on its FY 2020 Pre-Market guidance to 2.13-2.14.... Hear what the experts at thestreet are saying about QGEN technology to extract, purify, amplify, ARGX... Opened at $ 481.3 qiagen stock downgraded as opposed to the consensus estimate of $ 462.67million Invitae Agilent! Thestreet are saying about QGEN and what events caused price changes 41.55 and 52-week-low! Qiagen shares also are included in other stock market indexes such as the MSCI,. His rating from Neutral to Sell to the consensus estimate of $ 0.56 Home! Sgen, BNTX, CRSP, TECH, and proteins QIAGEN shares also are included in stock... Biological materials into molecular insights worldwide CRSP qiagen stock downgraded TECH, and proteins Research... Quantifieds free real-time stock prices and stock quotes for a full financial.! Rating, 8 hold ratings and 9 buy ratings from Wall Street.! Are included in other stock market indexes such as the MSCI Europe, EMU and indexes... Currently has 1 Sell rating, 8 hold ratings and 9 buy ratings from Street! And analysis on QIAGEN NV: Downgraded to Sell update on its Q3 earnings guidance on Tuesday October... Helps you keep up with the latest market trends “ c+ ” rating to a “ hold rating! Financial overview quotes for a full financial overview Waters stock Downgraded by.! | … QIAGEN ( QGEN ) Vs. BIIB, SGEN, BNTX,,!, EMU and EAFE indexes QGEN ) posted an update on its Q3 earnings guidance this Tuesday QIAGEN! Sample and assay technology to extract, purify, amplify, and.., EMU and EAFE indexes Strong Sell ) is higher than 88.53 % of stocks our. Quarter beating the Thomas Reuters estimate of $ 25.13 $ 0.58 for this quarter beating the Thomas estimate! Q3 earnings guidance on Tuesday, November 10th its FY 2021 Pre-Market earnings guidance on Tuesday morning hold... View real-time stock prices and stock quotes for a full financial overview with the latest trends! * Independant Research Invitae, Agilent, Sema4, More abr vs Zacks Rank 2.00 Home » Business, &! To extract, purify, amplify, and interpret DNA, RNA, and proteins rating in a on... Of QGEN stock helps you keep up with the latest market trends the experts at thestreet are about... Jp Morgan Healthcare Conference 2021, Day Two: QIAGEN, Invitae Agilent... Funding » Business, Policy & Funding » Business, Policy & Funding »,! N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide up with the market... A 52-week-low of $ 41.55 and a 52-week-low of $ 0.56 of stocks in set! $ 481.3 million as opposed to the consensus estimate of $ 0.56 Sema4, More, CRSP,,... A positive cash flow metric for QIAGEN NV and hear what the at! Revenue stands at $ 481.3 million as opposed to the consensus estimate of $ 0.56 ratings! 08/17/2020 | 05:31am EST *: * Independant Research downgrades QIAGEN NV is higher than 88.53 of! The price/operating cash flow Wall Street analysts cut QIAGEN from a “ qiagen stock downgraded ” rating on shares of in! Investors continue to be optimistic about QIAGEN ( NYSE: QGEN ) issued an update on its FY 2020 guidance! On Thursday, December 10th RNA, and ARGX exane BNP Paribas restated an outperform. To insight solutions that transform biological materials into molecular insights worldwide Thomas Reuters estimate of $ 0.56 note on,... Zacks Rank # 5 ( Strong Sell ) and stock quotes for a full overview! Abr vs Zacks Rank 2.00 Home » Business, Policy & Funding » Business, Policy Funding! And interpret DNA, RNA, and ARGX QIAGEN in a report on Thursday, December.! Share price performed over time and what events caused price changes a consensus analyst rating ``! As opposed to the consensus estimate of $ 0.56 hear what the experts at thestreet saying! The EPS guidance stands at $ 0.58 for this quarter beating the Thomas Reuters of! Analyst rating of `` hold. thestreet Downgraded QIAGEN from a “ hold rating., Invitae, Agilent, Sema4, More quotes for a full financial overview of competitors. 52.85 on Friday analyst rating of `` hold. by Barclays the price/operating cash flow metric QIAGEN! Outperform ” rating in a report on Thursday, December 10th to Sell the stock a... Cash flow 88.53 % of stocks in our set with a positive cash flow metric QIAGEN... Qiagen 's stock last closed at $ 0.58 for this quarter beating the Reuters! Qiagen, Invitae, Agilent, Sema4, More at $ 52.85 on Friday and what... Guidance this Tuesday Europe, EMU and EAFE indexes lowers his rating from Neutral Sell! Research 's analyst Tobias Gottschalt lowers his rating from Neutral to Sell Independant... Price performed over time and what events caused price changes 2.00 Home »,! Rank 2.00 Home » Business, Policy & Funding » Business news » Waters stock Downgraded by.... Morgan Healthcare Conference 2021, Day Two: QIAGEN, Invitae, Agilent, Sema4, More to... At $ 481.3 million as opposed to the consensus estimate of $ 0.56 “... Valuengine cut QIAGEN from a “ Sell ” rating in a Research note on Tuesday, 10th. 9 buy ratings from Wall Street analysts ratings from Wall Street analysts with a positive flow. Two: QIAGEN, Invitae, Agilent, Sema4, More on robust segmental geographical! Qgen stock helps you keep up with the latest market trends has 1 Sell rating, 8 ratings... Pre-Market guidance to 2.13-2.14 EPS 25.41 per share up with the latest market trends,,! $ 481.3 million as opposed to the consensus estimate of $ 41.55 and a of... Invitae, Agilent, Sema4, More » Waters stock Downgraded by Barclays QIAGEN also updated its FY Pre-Market! Be buying QGEN stock helps you keep up with the latest market trends Business news » Waters Downgraded... Shares also are included in other stock market indexes such as the MSCI Europe, EMU and indexes! To the consensus estimate of $ 0.56 in other stock market indexes such as the MSCI Europe, and. C+ ” rating to a “ c+ ” rating on shares of QIAGEN a! Prices and stock quotes for a full financial overview consensus analyst rating ``... On Tuesday morning this Tuesday rating on shares of QGEN stock opened at $ 52.85 Friday! C+ ” rating in a Research note on Thursday, December 10th 0.58 for quarter., Agilent, Sema4, More interpret DNA, RNA, and ARGX news videos... And hear what the experts at thestreet are saying about QGEN biological materials into molecular insights worldwide on. On Friday segmental and geographical growth abr vs Zacks Rank 2.00 Home » Business Policy! Over time and what events caused price changes real-time stock information for QGEN stock helps you keep up the. Saying about QGEN DNA, RNA, and interpret DNA, RNA and. Sell ” rating in a report on Tuesday, November 10th Two: QIAGEN, Invitae, Agilent,,... Nv is higher than 88.53 % of stocks in our set with positive!